Generics Bulletin: ジェネリック＆バイオシミラーニュース

Celltrion's Remsima SC Ready For Early 2020 Launch

By David Wallace 27 Nov 2020

Celltrion says it is ready to roll out its Remsima SC subcutaneous infliximab in Europe in the first quarter of 2020, after receiving a formal pan-European marketing authorization from the European Commission.

Topic Biosimilars Launches Regulation

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels

By Mandy Jackson 27 Nov 2020

Phase III results support early 2020 filings for what could be the RNAi specialist’s third commercial product, but two competing drugs for primary hyperoxaluria from Dicerna and OxThera aren’t far behind. 

Topic Clinical Trials Launches Rare Diseases

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

J.P. Morgan Conference Updates

By Mandy Jackson 22 Jan 2020

Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.

Topic Business Strategies Deals Launches Reimbursement

HBW Insight : コンシューマーヘルスケア産業のニュース

Reckitt Targets UK's Painful 'Tweens' With Double-Strength Nurofen

By David Ridley 18 Dec 2019

Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."

Topic Launches OTC Drugs

HBW Insight : コンシューマーヘルスケア産業のニュース

GSK Launches OTC Fluticasone In Japan Following Switch

By Tom Gallen 06 Dec 2019

GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.

Topic Launches Prescription to OTC Switch